Related Experiment Video
Updated: Feb 15, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
Published on: January 28, 2020
The evolving view of coronary artery calcium and cardiovascular disease risk
Isac C Thomas1,2, Nketi I Forbang2, Michael H Criqui2
1Division of Cardiovascular Medicine, Department of Medicine, University of California San Diego.
Insights
Coronary artery calcium (CAC) scoring may need reevaluation. Higher CAC density appears protective against cardiovascular disease (CVD) events, challenging traditional risk assessment models.
Area of Science:
- Cardiovascular Medicine
- Atherosclerosis Research
- Medical Imaging Analysis
Background:
- Coronary artery calcification (CAC) is linked to atherosclerosis and used in cardiovascular disease (CVD) risk assessment.
- Traditional CAC quantification (Agatston units) assumes higher density and area indicate greater risk.
- Emerging evidence suggests CAC may have protective aspects influencing future CVD risk.
Purpose of the Study:
- To re-evaluate the prognostic value of coronary artery calcium (CAC) in cardiovascular disease (CVD) risk assessment.
- To investigate the role of CAC density and plaque characteristics in modulating CVD risk.
- To explore potential plaque stabilization effects of vascular calcification.
Main Methods:
- Analysis of existing research and findings from studies like the Multi-Ethnic Study of Atherosclerosis (MESA).
- Review of studies using intracoronary ultrasound and coronary computed tomography angiography.
- Examination of the relationship between CAC quantification, plaque characteristics, and CVD events.
Main Results:
- Higher CAC density, contrary to previous assumptions, may be protective against coronary heart disease and CVD events.
- Calcified atherosclerotic plaque is associated with fewer CVD events compared to noncalcified or sparsely calcified plaque.
- Statins may be associated with increased CAC, despite their proven CVD benefits.
Conclusions:
- Current CAC quantification methods may require refinement.
- Vascular calcification's role in plaque stabilization warrants further investigation.
- CAC possesses underappreciated aspects that can modulate and potentially attenuate future CVD risk, necessitating a revised approach to risk assessment.
Abstract:
Calcification of the coronary artery is a complex pathophysiologic process that is intimately associated with atherosclerosis. Extensive investigation has demonstrated the value of identifying and quantifying coronary artery calcium (CAC) in atherosclerotic cardiovascular disease (CVD) prognostication. However, over the last several years, an increasing body of evidence has suggested that CAC has underappreciated aspects that modulate, and at times attenuate, future CVD risk. The most commonly used measure of CAC, the Agatston unit, effectively models both higher density and higher area of CAC as risk factors for future CVD events. Recent findings from the Multi-Ethnic Study of Atherosclerosis (MESA) have challenged this assumption, demonstrating that higher density of CAC is protective for coronary heart disease and CVD events. Statins may be associated with an increase in CAC, an unexpected finding given their clear benefits in the prevention and treatment of CVD. Studies utilizing intracoronary ultrasound and coronary computed tomography angiography have demonstrated that calcified atherosclerotic plaque-as compared with noncalcified or sparsely calcified plaque-is associated with fewer CVD events. These studies lend support to the often-asserted (but as yet unvalidated) view that calcification may play a role in plaque stabilization. Furthermore, vascular calcification, though a surrogate for atherosclerotic plaque burden, may also possess identifiable aspects that can refine CVD risk assessment.
More Related Videos
06:57Author Spotlight: Advancing Cardiovascular Imaging - Introducing the Spatially Weighted Calcium Score for Early Disease Detection
Published on: September 22, 2023
06:16Signal Acquisition, Score Interpretation, and Economics of a Non-Invasive Point-of-Care Test for Coronary Artery Disease
Published on: August 9, 2024
Related Concept Videos
Coronary Artery Disease I: Introduction
Coronary Artery Disease II: Pathophysiology
Coronary Artery Disease V: Interprofessional Care
Coronary Artery Disease III: Clinical Manifestations
Coronary Artery Disease IV: Preventive Measures
Psychoneuroimmunology: Cardiovascular Disease
A key area of focus in PNI is the relationship between stress and coronary...